# Effects of Saffron on Mild to Moderate Generalized Anxiety Disorder (GAD)

> **NCT02800733** · PHASE2,PHASE3 · UNKNOWN · sponsor: **National Nutrition and Food Technology Institute** · enrollment: 40 (estimated)

## Conditions studied

- Patients With Mild to Moderate GAD

## Interventions

- **DIETARY_SUPPLEMENT:** Saffron
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT02800733
- **Lead sponsor:** National Nutrition and Food Technology Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2016-08
- **Final completion:** 2016-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02800733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02800733, "Effects of Saffron on Mild to Moderate Generalized Anxiety Disorder (GAD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02800733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*